Merck SeronoHead Medical, Regulatory and Quality
Jan. 2009 - Mar. 2012Johannesburg Area, South AfricaProjects and highlights as Head of Medical • ObsErbi Clinical Trail
o Prospective open-label, international, observational trial on Erbitux
o Responsible for initiation, budget, launch, global extension and launch and trial management as well as management of the CRO o Study was initiated in Lebanon by Louis in May 2011 • DEuTSH study o First trial in Hypothyroidism in last 10 years
o 300 Patients planned at 60-70 GP’s in South Africa (311 recruited)
o Training of 360 GP’s on Hypothyroidism management by means of Road-shows across South Africa o Louis was responsible for initiation, budget, launch, training and trial management • Fixime study o Laboratory study to support the launch of Fixime into UTI market o Initiation during November 2010. o Shared public and private initiative along with Alexandra Clinic
o Third author on study o Poster presentation at FIDSAA 2011 and submitted for Publication Late 2012 • Highlights o Invited guest speaker: Nelson Mandela School of Medicine (January 2011)
o Invited guest speaker: African Hypertension Congress: Kenya (July 2011)
o Speaker tour: Clicks training (2010)
o Invited speaker: Clicks congress (2011)
o Speaker : Ethics lecture tour (June/July 2011)
o Creation/organisation and hosting of Merck Serono Health day (May 2011) o Presenter: ANC doctor’s forum (2011)
o Guest speaker: Launch Glucophage XR in Botswana (2011)
o Poster presentation FIDSAA congress 2011
o Guest speaker: Atlantic Physician’s congress (December 2011)
o Creation Skin Treatment program and patient support program Erbitux
o Establishing and management of Training Academy within Merck
o Oncology Mentor Africa and Middle East Region Reason for Leaving: Offered position as Medical Director Takeda